PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Gallant, Joel E.
TI  - What's New in Antiretroviral Therapy
DP  - 2012 Dec 01
TA  - MD Conference Express
PG  - 19--20
VI  - 12
IP  - 14
4099  - http://mdc.sagepub.com/content/12/14/19.short
4100  - http://mdc.sagepub.com/content/12/14/19.full
AB  - Current guidelines recommend non-nucleoside reverse transcriptase inhibitor (NNRTI)-based, boosted protease inhibitor (PI)-based, and integrase strand transfer inhibitor (INSTI)-based regimens for the treatment of HIV [http://aidsinfo.nih.gov/Guidelines/HTML/1/adult-and-adolescent-treatment-guidelines/0; Thompson MA et al. JAMA 2012]. This article discusss recent data from clinical trials comparing initial antiretroviral regimens and factors to be considered when starting antiretroviral therapy.